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Cyclic AMP increases rat inhibitor of apoptosis protein
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Cyclic AMP increases rat inhibitor of apoptosis protein (RIAP1) inhibit caspases and thus block intrinsic and extrinsic
mRNA in renal mesangial cells. pathways of programmed cell death. IAPs were first de-
Background. The cyclic adenosine 3,5-monophosphate scribed in baculovirus as proteins that inhibit cell death(cAMP) pathway plays a central role in the regulation of cell
and thus allow the virus to replicate efficiently in infectedproliferation, differentiation and apoptosis. Cyclic AMP has
cells. These evolutionary conserved proteins contain tan-been identified as a bifunctional regulator of apoptosis. The
inhibitor of apoptosis proteins (IAP) regulates apoptosis by dem repeats of domains, denoted as baculovirus IAP re-
directly inhibiting distinct caspases. peats (BIR domains). Some of them also contain a C-ter-
Methods. Expression levels of rat IAP (RIAP)-1 were inves- minal RING zinc-finger domain. At least seven differenttigated by RNase protection assay in rat mesangial cells after
mammalian IAPs, including X-chromosome-linked IAPstimulation with diverse agents that modulate cellular levels
(XIAP), cellular inhibitor of apoptosis protein 1 (cIAP-1),of cAMP.
Results. Rat mesangial cells up-regulated RIAP1 mRNA cIAP-2, neuronal apoptotic inhibitory protein (NAIP),
levels after cAMP stimulation. Membrane-permeable cAMP ML-IAP, apollon and survivin are known to exhibit anti-
analogs, as well as cAMP production in response to the -adren-
apoptotic activity [1].ergic receptor agonist salbutamol caused a large increase in
It is not yet fully understood how these proteins areRIAP1 mRNA level, which could be inhibited by the protein
kinase A inhibitors H89 and Rp-cAMPS, or by the nuclear regulated in cells and tissues. Some IAPs are known to
factor-B (NF-B) inhibitor BAY117085. Inhibition of phos- be regulated by nuclear factor-B (NF-B), and thus
phodiesterase type IV by denbufyllin or rolipram potentiated might intersect with the apoptotic pathway and explain,
the cAMP-mediated increase in RIAP1 mRNA. In contrast,
at least partially, the anti-apoptotic effects of NF-Bthe cyclic guanosine 3,5-monophosphate (cGMP) analog
[3–5]. Moreover, IAP regulation by nitric oxide [6] andBt2cGMP did not affect the RIAP1 mRNA level.
Conclusions. These data establish, to our knowledge for the hypoxia [7] has been observed to involve non-conven-
first time, that RIAP1 mRNA levels are regulated by the tional pathways of gene transcription. Glucocorticoids
cAMP-signaling pathway and suggest potential new avenues also have been reported to induce IAP expression or toof therapy to modulate apoptosis.
prevent IAP degradation, and thus suppress inflamma-
tory responses and prevent cells from undergoing apo-
ptosis [8, 9]. This article reports that cyclic 3,5-mono-Regulation of cell homeostasis in multicellular organ-
phosphate (cAMP) up-regulates cIAP1 (RIAP1 in theisms involves the generation of new cells as well as re-
rat) in rat mesangial cells, which may strengthen theirmoval of unwanted or damaged cells by cell death. There
commitment to live and subsequently alter the courseexists in all cells the necessary equipment for pro-
of inflammatory glomerular diseases.grammed cell death (apoptosis), which usually is sup-
pressed when a cell is doing well but allows rapid cell
death when required. Caspases are the major execution- METHODS
ers of apoptosis, as they initiate a self-amplifying cascade Materials
of autoactivation as well as cleave many proteins to en-
RNases A, RNase T1, RNA polymerase T3 and T7sure cellular homeostasis [1, 2]. A powerful barrier
were from Roche Molecular Biochemicals (Mannheim,against uncontrolled activation of caspases is the inhibi-
Germany). N6,O2-dibutyryl-cAMP (Bt2cAMP), N6,O2-tor of apoptosis (IAP) proteins that directly bind to and
dibutyryl-cGMP (Bt2cGMP), 8-bromo-cAMP (Br-cAMP),
8-(4-chlorophenylthio)-cAMP (8-CPTcAMP), forskolin,
cholera toxin Inaba 569B, 3-isobutyl-1-methylxanthineKey words: apoptosis, protein kinase A, nuclear factor-B, cyclic GMP,
inflammatory glomerular disease. (IBMX), pyrrolidine dithiocarbamate (PDTC) and gua-
nidine isothiocyanate were purchased from Sigma (Dei- 2002 by the International Society of Nephrology
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senhofen, Germany). Adenosine-3,5-cyclic monophos- separated on 5% acrylamide/8 mol/L urea gels and ana-
phorothioate (Rp-Isomer, triethylammonium salt), H89, lyzed using a PhosphoImager (Fuji, Tokyo, Japan). All
Cilostamide, Rolipram, Denbufyllin and BAY117085 protection assays were carried out with at least three
were purchased from Calbiochem (Bad Soden, Ger- different sets of RNA from independent experiments.
many). RPMI 1640, Dulbecco’s modified Eagle’s me-
Western blot analysisdium (DMEM), cell culture supplements and fetal calf
serum (FCS) were from Gibco (Eggenstein, Germany). Cells were cultured and incubated as indicated. Cell
All other chemicals were of the highest grade of purity lysis and immunoblotting was performed as previously
commercially available. described [6].
Cell culture and cell treatment
RESULTSRat renal mesangial cells were cultured and character-
ized as described previously [10]. In a second step, single Cyclic AMP increases RIAP-1 mRNA levels in
cells were cloned by limited dilution of 96-well plates mesangial cells
[11]. For the experiments in this study passages 13 to 23
Mesangial cells were incubated with forskolin andwere used.
after a period of eight hours there was a significant andCells were cultured in RPMI 1640 medium containing
time-dependent increase in RIAP1 mRNA levels (Fig.10% FCS, penicillin (100 U/mL), and streptomycin (100
1A). This response to forskolin was dose-dependent,g/mL). For all experiments, subconfluent cells were
with a threshold at 10 mol/L forskolin. In the presencestarved for 24 hours and exposed to the different sub-
of 10 mol/L forskolin, cAMP levels in mesangial cellsstances in starvation medium (DMEM containing 0.1
increased 14-fold during the first hours and remained atmg/mL fatty acid-free BSA, penicillin 100 U/mL, and
an elevated concentration during at least 24 hours ofstreptomycin 100 g/mL).
incubation [12].
Probe DNAs The diterpene forskolin is known to activate adenylate
cyclase by direct stimulation of the catalytic submit of theAll the cDNA fragments used as probes for RNase
enzyme. We next investigated the effects of the -adren-protection assays were cloned by polymerase chain reac-
oceptor agonist salbutamol and cholera toxin, two com-tion (PCR) using the following sequences as nucleotide
primers, purchased from Life Technologies (Eggenstein, pounds that activate adenylate cyclase system by differ-
Germany): ent mechanisms, on RIAP1 mRNA levels.
Rat IAP1 probe: 5-CTC ATG (GC)AC AAA ACT Salbutamol binds to -adrenoceptors on the cell sur-
G(CT)C TCC-3was used as a 5-primer and 5-CT(AG) face of mesangial cells [13] and activates adenylate cy-
GG(AG) TA(GCT) A(AGC)C T(GT)T (CT)T(AG) clase via the stimulatory G-protein, Gs. Cholera toxin
TGC-3 as a 3-primer. causes adenosine diphosphate (ADP)-ribosylation of Gs,
Rat -actin probe: 5-ATG GAT GA(CT) GAT ATC thus altering this G-protein to a state of permanent acti-
GC(TC) GCG-3 was used as a 5-primer and 5-ATG vation, leading to the subsequent stimulation of the cata-
GGG TAC TTC AGG GT(CG) AGG-3 as a 3-primer. lytic moiety of adenylate cyclase. As depicted in Fig-
Rat GAPDH probe: 5-CAT CAC CAT CTT CCA ure 1B for cholera toxin and in Figure 1C for salbutamol,
GGA GCG AG-3 as a 5-primer and 5-GTT GTC both agents enhanced RIAP1 mRNA levels in a time-
ATA (CT)TT CTC (AG)TG GTT C-3 as a 3-primer. and dose-dependent manner. In a further approach the
membrane-permeant analogs of cAMP (Bt2 cAMP, 8-Br-RNA isolation and RNase protection analysis
cAMP and 8-CPT-cAMP) were used to elevate the intra-
RNA isolation was performed as described [6]. Twenty
cellular concentration of cAMP directly. Figure 1Amicrograms of total RNA from the different experimen-
clearly shows that all cAMP analogs increased RIAP1tal time points of the cell culture experiments were used
mRNA levels in mesangial cells. In addition, the broadfor RNase protection assays. DNA probes were cloned
spectrum phosphodiesterase inhibitor 3-isobutyl-1-meth-into the transcription vectors pBluescript II KS() (Stra-
ylxanthine and the selective inhibitors of phosphodies-tagene, Heidelberg, Germany) or pCR2.1-TOPO (Invi-
terase 4, rolipram and denbufyllin, but not the selectivetrogen, Leek, Netherlands) and linearized. An anti-sense
inhibitor of phosphodiesterase 3, cilostamide (which in-transcript (riboprobe) was synthesized in vitro using T3
crease cAMP by inhibiting the enzymes that degrade it),or T7 RNA polymerase and [32P]UTP (800 Ci/mmol;
also moderately enhanced RIAP1 mRNA levels (dataAmersham, Freiburg, Germany). RNA samples were
not shown) and a combination of IBMX with salbutamolhybridized at 42C overnight with 100,000 cpm of the
resulted in a synergistic up-regulation of RIAP1 mRNAriboprobe. Hybrids were digested with a mix of RNase A
and T1 for one hour at 30C. Protected fragments were (Fig. 1C).
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Fig. 1. Cyclic adenosine 3,5-monophosphate (cAMP) increases rat inhibitor of apoptosis protein (RIAP1) mRNA expression in renal mesangial
cells. Rat renal mesangial cells were incubated for the indicated time periods with (A) forskolin (10 g/mL), N6,O2-dibutyryl-cAMP (Bt2cAMP, 1
mmol/L), 8-bromo-cAMP (Br-cAMP, 1 mmol/L, 8-(4-chlorophenylthio)-cAMP (8-CPTcAMP, 1 mmol/L) or with (B) cholera toxin (1.0 g/mL,
0.1 g/mL 0.01 g/mL) or with (C) salbutamol (50 mol/L) alone or in combination with 3-isobutyl-1-methylxanthine (IBMX, 500 mol/L) or
Cilostamide 700 nmol/L, as indicated. 20 g total RNA were analyzed by RNase protection assay. The RIAP1 mRNA expression levels were
assessed by PhosphorImager analysis of the radiolabeled gels. Representative RNase protection gels from three independent experiments are
presented.
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Fig. 2. Inhibition of protein kinase A (PKA)
blocks RIAP1 mRNA expression in renal
mesangial cells. Rat renal mesangial cells were
incubated for the indicated time periods with
forskolin (10mol/L) alone or in combination
with RPcAMPS (10 mol/L). A representa-
tive RNase protection gel out of three inde-
pendent experiments is presented.
Cyclic GMP does not increase RIAP1 mRNA levels tramer of paired regulatory and catalytic subunits under
in mesangial cells basal conditions. Binding of cAMP causes the dissocia-
tion of the heterotetramer and liberates the catalyticIncubation of mesangial cells with the membrane-per-
subunits that translocate to the nucleus and alter genemeable cyclic guanosine 3,5-monophosphate (cGMP)
expression by phosphorylating cAMP response elementanalog Bt2 cGMP did not alter RIAP1 mRNA levels
(CRE)-binding protein (CREB) [15]. To determine(data not shown). Furthermore, inhibition of soluble
whether PKA activation triggers RIAP1 expression weguanylate cyclase by the specific inhibitor NS 2028 had
used a specific inhibitor of PKA, the cyclic cAMP analognot effect on RIAP1 mRNA levels. (data not shown).
RpcAMPS [16]. As shown in Figure 2, RpcAMPS (10Recently we have demonstrated that nitric oxide (NO)
mol/L) caused a marked inhibition of forskolin-inducedup-regulates RIAP1 mRNA in mesangial cells [6]. As it
RIAP1 expression, thus confirming the crucial role foris well established that cAMP mediates expression of
PKA in cAMP-induced RIAP1 expression. Surprisingly,inducible nitric oxide synthase (iNOS) in rat mesangial
BAY 117085, an inhibitor of IB kinase and NF-Bcells [12, 14] and increases NO production by the cells,
signaling in mesangial cells, blocked forskolin-inducedwe evaluated whether the cAMP-induced RIAP1 ex-
RIAP1 mRNA expression (Fig. 3). Although most Relpression is triggered by prior formation of nitric oxide.
proteins (subunits that form the transcription factor NF-To this end mesangial cells were incubated with Bt2
B) have consensus recognition sites for PKA phosphor-cAMP in the presence or absence of the nitric oxide
ylation and cAMP has been shown to activate NF-B insynthase inhibitor L-NG-monomethyl-l-arginine and de-
certain cell types [17], it has been clearly documentedtermined RIAP1 expression. There was no significant
that cAMP does not activate NF-B in mesangial cellsalteration of RIAP1 expression by the NOS inhibitor
[18, 19]. Obviously, pharmacological inhibitors do not(data not shown), suggesting that cAMP directly alters
always give satisfactory answers because many of thesegene expression of RIAP1.
compounds are not highly specific and do not only inhibit
Inhibition of protein kinase A blocks RIAP1 their supposed target enzymes.
mRNA expression
Cyclic AMP does not alter RIAP1 protein levelsIncreased formation of cAMP signals most cellular
Because the effect of nitric oxide on RIAP1 expressionresponses through activation of the cAMP-dependent
protein kinase (PKA), which is a cytoplasmic heterote- in mesangial cells was limited to mRNA regulation, with
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Fig. 3. BAY 117085 blocks RIAP1 mRNA
expression in renal mesangial cells. Rat re-
nal mesangial cells were incubated for the
indicated time periods with forskolin (10
mol/L) alone or in combination with BAY
117085 (30 mol/L), as indicated. 20 g total
RNA were analyzed by RNase protection
assay. The RIAP1 mRNA expression levels
were assessed by PhosphorImager analysis of
the radiolabeled gels. Representative RNase
protection gels from three independent exper-
iments are presented.
Fig. 4. Effect of cAMP on RIAP1 protein in renal mesangial cells. Rat renal mesangial cells were incubated for the indicated time periods with
vehicle (control) or cholera toxin (1.0 g/mL, 0.1 g/mL, 0.01 g/mL) for the indicated time periods. 50 g total protein were analyzed by Western
blot, followed by enhanced chemiluminescence detection and video densitometry. Each blot is representative of three similar experiments.
only marginally changes in RIAP1 protein levels, we remarkably, NO [6] has been observed. Previous investi-
gations suggested that IAP expression by cytokines suchnext investigated the effects of cAMP on RIAP1 protein
as TNF, bacterial endotoxins and ionizing radiationlevels. Surprisingly, RIAP1 mRNA up-regulation by
occurs through NF-B [3–5, 24, 25]. Our investigationcholera toxin (Fig. 4) or forskolin (data not shown) did
found, to our knowledge for the first time, that thenot result in RIAP1 protein up-regulation in mesangial
cAMP/PKA pathway is an alternative pathway of tran-cells, indicating that changes in RIAP1 mRNA do not
scriptional regulation of IAP expression and may consti-necessarily translate into changes in protein levels.
tute a powerful protective agent in cells exposed to stress
conditions. In this context, type I PKA has been reported
DISCUSSION to delay apoptosis in response to different stimuli in
Excessive proliferation of mesangial cells is a charac- human neutrophils at a site upstream of caspase 3 [26],
teristic feature of many glomerular diseases caused by and expression of PKA inhibitor gene was found to abol-
diverse immunological and non-immunological injuries. ish cAMP-mediated protection to endothelial barrier
The initial phase of injury as well as resolution of hyper- dysfunction [27]. Moreover, cAMP-derived signaling and
proliferative glomerular diseases have been shown to gene expression inhibit apoptosis in macrophages [28]
involve apoptosis of mesangial cells to avoid aberrant and vascular smooth muscle cells [29]. Several mecha-
wound healing responses and fibrosis [2, 20]. In molecu- nisms have been proposed for the anti-apoptotic action
lar terms, a family of proteases, the caspases, has been of cAMP signaling, including cross-talk to the mitogen-
identified as a pivotal executioner of programmed cell activated protein kinase pathway [26], changes in intra-
death. Primarily activation of caspase 3 may mark a point cellular Ca2mobilization, interference with cytoskeletal
of no return in the apoptotic cascade [1]. Therefore, it reorganization and expression of protective mediators
is not surprising that IAPs are ubiquitously expressed like cyclooxygenase 2 [28]. We now provide convincing
to halt the caspase cascade unless apoptosis is actually evidence that the expression of IAPs is regulated by
required. Expression of IAPs has been reported in hu- cAMP and may provide a powerful brake to cellular
man kidneys [21, 22] and recently regulation of IAP apoptotic processes. Recently, a 3.5 kb fragment of the
expression in mesangial cells in response to interleukin-1 5-flanking region of the human c-IAP2 gene has been
cloned, and several potential binding sites for diverse(IL-1) [6], tumor necrosis factor- (TNF) [6, 23] and,
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